Insider Signal Report — 2026-06-14
Scan covers trade_date 2026-06-09 → 2026-06-14 | 16 qualifying trades scanned | 2 signals detected
★★★★ Informed Accumulation
Criteria: Repeat Buyer + Prior 30d −10% to −20%
Insider with a prior purchase in the same ticker within 2 years, adding to position after a 10–20% pullback. Deep institutional knowledge + deliberate price discipline. EV ~20–30%+ at 12–15m. Cross-check business quality — serial buyers into structural decline are noise.
Target Hold: 12–15 months
| Ticker | Company | Trade Date | Insider | Title | Value | Prior 30d | C-Suite | New Pos | Also Qualifies |
|---|---|---|---|---|---|---|---|---|---|
| MP | MP Materials Corp. / DE | 2026-06-09 | Rosenthal Michael Stuart | Chief Operating Officer | $543K | -19.4% | ✓ | — | — |
★★★ Momentum Confirmation
Criteria: Insider Buy After >+10% Prior Month
Any insider buying ≥$200k after the stock already moved up >10% in the prior month. Counter-intuitive but data-backed: exec sees real fundamental improvement behind the move. EV +17–34% through 9m — exit at 9m as performance degrades past that point.
Target Hold: 6–9 months
| Ticker | Company | Trade Date | Insider | Title | Value | Prior 30d | C-Suite | New Pos | Also Qualifies |
|---|---|---|---|---|---|---|---|---|---|
| AAT | American Assets Trust, Inc. | 2026-06-10 | RADY ERNEST S | Executive Chairman | $739K | +18.5% | ✓ | — | — |
Notable Buys — No Strategy Match
Trades ≥$500,000 that didn't meet any strategy filter. Often in the −5% to 0% prior-return zone (weakest bucket) or missing price data.
| Ticker | Company | Trade Date | Insider | Title | Value | Prior 30d | C-Suite | New Pos | Also Qualifies |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | 2026-06-11 | Kolchinsky Peter | maybe director | $423.8M | N/A | — | ✓ | — |
| PBLS | Parabilis Medicines, Inc. | 2026-06-11 | RA Capital Healthcare Fund LP | maybe director | $423.8M | N/A | — | ✓ | — |
| PBLS | Parabilis Medicines, Inc. | 2026-06-11 | RA Capital Nexus Fund III, L.P | maybe director | $423.8M | N/A | — | ✓ | — |
| PBLS | Parabilis Medicines, Inc. | 2026-06-11 | Shah Rajeev M. | maybe director | $423.8M | N/A | — | ✓ | — |
| SMMT | Summit Therapeutics Inc. | 2026-06-12 | DUGGAN ROBERT W | Co-Chief Executive Officer | $50.0M | -25.4% | ✓ | — | — |
| SMMT | Summit Therapeutics Inc. | 2026-06-12 | Zanganeh Mahkam | Co-Chief Executive Officer | $50.0M | -25.4% | ✓ | — | — |
| FBIN | Fortune Brands Innovations, Inc. | 2026-06-10 | GARDEN EDWARD P | maybe director | $13.0M | +7.8% | — | — | — |
| AMR | Alpha Metallurgical Resources, Inc. | 2026-06-12 | Courtis Kenneth S. | maybe director | $2.0M | +11.9% | — | — | — |
| VFC | V F CORP | 2026-06-09 | Carucci Richard | maybe director | $515K | -5.2% | — | — | — |
Signal Summary
| Rating | Strategy | Signals |
|---|---|---|
| ★★★★★ | Conviction Bottom | 0 |
| ★★★★ | Informed Accumulation | 1 |
| ★★★★ | Fresh Conviction Entry | 0 |
| ★★★ | Momentum Confirmation | 1 |
| ★★ | Fallen Knife w/ Insider Backstop | 0 |
Generated 2026-06-14 · Strategies based on backtests 2021–2026 on US insider purchases